210 related articles for article (PubMed ID: 19504989)
1. [Cardiac surgery in patients with heparin-induced thrombocytopenia (HIT II)].
Jović MD; Nezić DG; Calija BM; Nenadić DS; Knezević AM; Borzanović MD; Krivokapić BM; Petrović IM; Djukanović BP
Acta Chir Iugosl; 2009; 56(1):47-52. PubMed ID: 19504989
[TBL] [Abstract][Full Text] [Related]
2. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
Westphal K; Martens S; Strouhal U; Matheis G; Lindhoff-Last E; Wimmer-Greinecker G; Lischke V
Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
[TBL] [Abstract][Full Text] [Related]
3. [Use of Organon, a synthetic heparinoid, in two cardiopulmonary bypass procedures in the same patient sensitive to heparin].
Pineau E; Le Bret E; Folliguet T; Saint Maurice OS; Carbognani D; Laborde F
Arch Mal Coeur Vaiss; 2001 Feb; 94(2):144-7. PubMed ID: 11265553
[TBL] [Abstract][Full Text] [Related]
4. [Thrombosis of a cardiopulmonary bypass circuit despite recommended hypocoagulation with danaparoid during the acute phase of type II heparin-induced thrombocytopenia].
Salmi L; Elalamy I; Leroy-Matheron C; Houel R; Thébert D; Duvaldestin P
Ann Fr Anesth Reanim; 2006; 25(11-12):1144-8. PubMed ID: 17174213
[TBL] [Abstract][Full Text] [Related]
5. Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
Olin DA; Urdaneta F; Lobato EB
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):707-9. PubMed ID: 11139115
[No Abstract] [Full Text] [Related]
6. [Extracorporeal circulation with danaparoid sodium for valve replacement in thrombocytopenia induced by type II heparin].
Salmi L; Leroy-Matheron C; LeBesnerais P; Rosanval O; Duvaldestin P; Gouault-Heilmann M
Ann Fr Anesth Reanim; 2001 Nov; 20(9):799-802. PubMed ID: 11759322
[TBL] [Abstract][Full Text] [Related]
7. Heparin induced thrombocytopenia. Experiences in 12 heart surgery patients.
Sodian R; Loebe M; Gorman KF; Riess H; Hetzer R
ASAIO J; 1997; 43(5):M430-3. PubMed ID: 9360077
[TBL] [Abstract][Full Text] [Related]
8. Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid.
Kanagasabay R; Unsworth-White MJ; Farnsworth G; Haxby EJ; Smith EE
J Thorac Cardiovasc Surg; 2000 Aug; 120(2):428-9. PubMed ID: 10917979
[No Abstract] [Full Text] [Related]
9. The management of heparin-induced thrombocytopenia.
Keeling D; Davidson S; Watson H;
Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II.
Christiansen S; Jahn UR; Meyer J; Scheld HH; Van Aken H; Kehrel BE; Hammel D
Ann Thorac Surg; 2000 Mar; 69(3):774-7. PubMed ID: 10750760
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia: a frequent complication after cardiac surgery.
Pouplard C; Regina S; May MA; Gruel Y
Arch Mal Coeur Vaiss; 2007; 100(6-7):563-8. PubMed ID: 17893639
[TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172.
Wilhelm MJ; Schmid C; Kececioglu D; Möllhoff T; Ostermann H; Scheld HH
Ann Thorac Surg; 1996 Mar; 61(3):920-4. PubMed ID: 8619718
[TBL] [Abstract][Full Text] [Related]
13. Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran).
Saxon BR; Black MD; Edgell D; Noel D; Leaker MT
Ann Thorac Surg; 1999 Sep; 68(3):1076-8. PubMed ID: 10510017
[TBL] [Abstract][Full Text] [Related]
14. Cross-Reactivity Between Heparin and Danaparoid Antibodies in Cardiac Surgery.
Ronchard T; Salaun E; Theron A; Grisoli D; Jaussaud N; Collart F; Habib G; Camoin-Jau L
Ann Thorac Surg; 2017 Jan; 103(1):e9-e10. PubMed ID: 28007287
[TBL] [Abstract][Full Text] [Related]
15. Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Am J Cardiovasc Drugs; 2001; 1(6):429-43. PubMed ID: 14728002
[TBL] [Abstract][Full Text] [Related]
16. Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia.
Gillis S; Merin G; Zahger D; Deeb M; Drenger B; Hyam E; Eldor A
Br J Haematol; 1997 Sep; 98(3):657-9. PubMed ID: 9332322
[TBL] [Abstract][Full Text] [Related]
17. Failure of danaparoid anticoagulation for cardiopulmonary bypass.
Ariano RE; Bhattacharya SK; Moon M; Brownell LG
J Thorac Cardiovasc Surg; 2000 Jan; 119(1):167-8. PubMed ID: 10612777
[No Abstract] [Full Text] [Related]
18. Coronary artery bypass grafting in a patient with type II heparin associated thrombopenia.
Christiansen S; Geiger A; Splittgerber FH; Reidemeister JC
Cardiovasc Surg; 1998 Feb; 6(1):90-3. PubMed ID: 9546852
[TBL] [Abstract][Full Text] [Related]
19. Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox
Hassen K; Maccaroni MR; Sabry H; Mukherjee S; Serumadar S; Birdi I
Perfusion; 2018 Apr; 33(3):235-240. PubMed ID: 28789610
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopaenia.
Prince M; Wenham T
Postgrad Med J; 2018 Aug; 94(1114):453-457. PubMed ID: 30126928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]